Join Our Talent Community! at Shape Therapeutics

Seattle, Washington, United States

Shape Therapeutics Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

  • Dynamic professionals
  • Diversity of thought
  • Scientific knowledge
  • Professional rigor
  • Focus on making cures a reality

Responsibilities

  • (None explicitly specified)

Skills

Key technologies and capabilities for this role

RNA editingAAV vectorsgene therapybiomanufacturingmolecular biologybiotechnology

Questions & Answers

Common questions about this position

Is this position remote or onsite?

The position is onsite.

What benefits does Shape Therapeutics offer?

Benefits include medical, dental, and vision coverage for employees and dependents, 12 paid holidays plus a one-week winter break, robust paid parental leave, annual employee stipend, flex PTO, company-paid long-term disability, and voluntary 401k, life/AD&D, and FSAs.

What skills or qualifications are required?

This information is not specified in the job description.

What is the company culture like at Shape Therapeutics?

The company values a dynamic team with diversity of thought, scientific knowledge, professional rigor, and a focus on making cures a reality, while aspiring to Shape Life! through commitment to an inclusive environment.

How do I apply if there's no suitable job opening?

Send your resume to the company if interested in joining the team but no suitable opportunity is available; they will keep your information on file and contact you if a match is found.

Shape Therapeutics

Develops programmable RNA medicines using AI

About Shape Therapeutics

Shape Therapeutics specializes in programmable RNA medicine, using artificial intelligence to analyze large datasets for new treatment development. Their technology, RNAfix, modifies RNA instructions to correct genetic mutations without changing DNA, while smart-sensing vector designs allow for tailored gene expression in specific cell types. The company aims to create effective and safe medicines that address the root causes of diseases, distinguishing itself by combining AI with RNA-based therapies.

Seattle, WashingtonHeadquarters
2018Year Founded
$143.5MTotal Funding
SERIES_BCompany Stage
AI & Machine Learning, BiotechnologyIndustries
51-200Employees

Risks

Intellectual property disputes may arise in the competitive RNA therapy field.
Regulatory challenges due to rapid AI and RNA advancements could impact ShapeTX.
Talent war in biotech may lead to recruitment challenges for ShapeTX.

Differentiation

ShapeTX uses AI to design novel RNAs for precise gene therapy.
Their RNAfix technology corrects RNA without altering DNA, offering unique therapeutic potential.
Smart-sensing vector designs enable tailored gene expression, surpassing first-generation gene therapies.

Upsides

Increased interest in RNA therapies boosts ShapeTX's market potential.
AI integration in drug discovery enhances ShapeTX's innovative capabilities.
FDA fast-tracking of RNA therapies supports ShapeTX's regulatory pathway.

Land your dream remote job 3x faster with AI